- $69.87m
- $354.53m
- $570.78m
Annual income statement for Vivid Seats, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 443 | 600 | 713 | 776 | 571 |
| Cost of Revenue | |||||
| Gross Profit | 352 | 460 | 531 | 574 | 397 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 402 | 526 | 632 | 733 | 1,351 |
| Operating Profit | 40.7 | 73.8 | 81.3 | 42.2 | -780 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -18.8 | 69.2 | 70.9 | 22.7 | -652 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -19.1 | 70.8 | 113 | 14.3 | -721 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -16.1 | 28.7 | 74.5 | 9.43 | -429 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -3.28 | 70.8 | 74.5 | 11.7 | -429 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 5.16 | 7.91 | 8.39 | 1.75 | 7.08 |
| Special Dividends per Share |